Johnson & Johnson (LON:0R34)

London flag London · Delayed Price · Currency is GBP · Price in USD
190.51
-1.66 (-0.86%)
At close: Oct 24, 2025
-0.86%
Market Cap344.07B
Revenue (ttm)68.71B
Net Income (ttm)18.73B
Shares Outn/a
EPS (ttm)7.72
PE Ratio18.37
Forward PE16.94
Dividend3.90 (2.05%)
Ex-Dividend DateAug 26, 2025
Volume6,514
Average Volume8,084
Open192.10
Previous Close192.18
Day's Range189.48 - 193.61
52-Week Range138.93 - 196.00
Betan/a
RSI60.25
Earnings DateJan 21, 2026

About Johnson & Johnson

Johnson & Johnson, together with its subsidiaries, engages in the research and development, manufacture, and sale of various products in the healthcare field worldwide. It operates in two segments, Innovative Medicine and MedTech. The Innovative Medicine segment offers products for various therapeutic areas, such as immunology, including rheumatoid arthritis, psoriatic arthritis, inflammatory bowel disease, and psoriasis; infectious diseases comprising HIV/AIDS; neuroscience, consisting of mood disorders, neurodegenerative disorders, and schizo... [Read more]

Industry Pharmaceutical Preparations
Founded 1886
Employees 138,100
Stock Exchange London Stock Exchange
Ticker Symbol 0R34
Full Company Profile

Financial Performance

In 2024, Johnson & Johnson's revenue was $88.82 billion, an increase of 4.30% compared to the previous year's $85.16 billion. Earnings were $14.07 billion, a decrease of -59.99%.

Financial numbers in USD Financial Statements

News

There is no news available yet.